Header Logo

Connection

ABDUL AZIZ SIDDIQUI to Male

Back to Details
This is a "connection" page, showing publications ABDUL AZIZ SIDDIQUI has written about Male.
ABDUL AZIZ SIDDIQUI
Connection Strength
0.010
Male
  1. Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trial. Nat Med. 2025 Oct; 31(10):3504-3513.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.